Achieve Life Sciences (ACHV) Exchange Rate Effect (2010 - 2025)
Achieve Life Sciences' (ACHV) quarterly Exchange Rate Effect came in at $4000.0 in Q4 2025, up 300.0% on a QoQ basis from -$2000.0 in Q1 2025.
Powered by 
Analysis
Achieve Life Sciences (ACHV) Exchange Rate Effect (2010 - 2025) Analysis & Trends
Achieve Life Sciences (ACHV) has 13 years of Exchange Rate Effect data on file, last reported at $4000.0 in Q4 2025.
- Quarterly Exchange Rate Effect changed N/A year-over-year to $4000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3000.0 (changed N/A YoY) and the FY2025 annual result came in at $3000.0, changed N/A from the prior year.
- Exchange Rate Effect climbed to $4000.0 in Q4 2025, from -$2000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $4000.0 in Q4 2022 to a low of -$3000.0 in Q3 2021.
- A 4-year average of $428.57 and a median of -$1000.0 in 2022 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 0.0% in 2023, down 0.0% in 2023.
- Tracing ACHV's Exchange Rate Effect over 4 years: stood at -$3000.0 in 2021, then soared by 233.33% to $4000.0 in 2022, then slumped by 50.0% to $2000.0 in 2023, then surged by 100.0% to $4000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $4000.0 (Q4 2025), -$2000.0 (Q1 2025), and $2000.0 (Q2 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Achieve Life Sciences | 369.90 Mn | 369.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 4,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Sep 30, 2021 | -3,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Sep 30, 2019 | 1,000.00 |
| Jun 30, 2019 | -2,000.00 |
| Mar 31, 2019 | 4,000.00 |
| Mar 31, 2018 | -1,000.00 |
| Dec 31, 2017 | -8,000.00 |
| Sep 30, 2017 | 5,000.00 |
| Mar 31, 2017 | 2,000.00 |
| Jun 30, 2014 | -1,000.00 |
| Mar 31, 2014 | -1,000.00 |
| Dec 31, 2013 | 2,000.00 |
| Sep 30, 2013 | 25,000.00 |